Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Stock Movers: Agios Pharma, Rivian, Fiserv
Stock Movers: Agios Pharma, Rivian, Fiserv
Bloomberg

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…

newswire.ca - Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
CNW

EAST RUTHERFORD, N.J., July 7, 2026 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the…

thehindubusinessline.com - Broker's Call: Mankind Pharma (Add)
Broker's Call: Mankind Pharma (Add)
BusinessLine

After years of growth led by distribution reach and prescription volume, Mankind Pharma is re-orienting towards research-led, niche and specialty therapies where competition is thinner. A calculated move into low-competition specialty niches is a…

newswire.ca - Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
CNW

MUMBAI, India, July 7, 2026 /CNW/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global…

thehindubusinessline.com - Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger
Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger
BusinessLine

Shares of Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals surged to fresh 52-week highs on Tuesday after the National Company Law Tribunal's Ahmedabad Bench sanctioned the merger of JB Chemicals into Torrent Pharmaceuticals on Monday…

forbes.com - Kamya Elawadhi - Five Ways AI Is Transforming Healthcare Marketing
Five Ways AI Is Transforming Healthcare Marketing
Forbes

Kamya Elawadhi is Co-Founder and President at Doceree. Healthcare marketing has always been complex. The audiences are more specialized than in almost any other industry, every interaction lives inside a strict regulatory environment and the…

investors.com - ALLISON GATLIN - Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Investor's Business Daily

Eli Lilly (LLY) shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill. Kailera's partner, Hengrui Pharma, ran two studies in patients in China. But the results seemingly paled…

globenewswire.com - Biocartis NV - Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
GlobeNewswire

PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics ITASCA, IL, US and HUNTSVILLE, AL, US – July 07, 2026. Today, Biocartis, an…

forbes.com - Bruce Japsen - Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
Forbes

News The Cigna Group's Evenorth health services business has committed $100 million to support a new artificial intelligence-powered pharmacy program and a private equity firm's purchase of Asembia are only the latest in a wave of huge investments…

bbc.co.uk - Nikhil Inamdar - Philanthropy: From temples to technology - India's wealthy are finally giving to science - India's wealthy are finally giving to science
Philanthropy: From temples to technology - India's wealthy are finally giving to science - India's wealthy are finally giving to science
BBC

Last year, Indian-American physicist Jainendra Jain, a co-recipient of the prestigious 2025 Wolf Prize and a figure well-known for his revolutionary research in quantum physics, was taken aback when he received a call from an Indian real estate…

seekingalpha.com - High Alpha Professor - IDEXX Laboratories Does Not Need More Vet Visits--But It Needs More Tests Per Visit (NASDAQ:IDXX)
IDEXX Laboratories Does Not Need More Vet Visits--But It Needs More Tests Per Visit (NASDAQ:IDXX)
Seeking Alpha

IDEXX Laboratories (IDXX) is rated Hold, as its premium valuation (~38x 2026E EPS) already assumes strong recurring revenue and diagnostics growth. IDXX is growing diagnostics revenue despite declining veterinary visits, leveraging inVue Dx and…

seekingalpha.com - Galzus Research - Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS)
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS)
Seeking Alpha

Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor destruction with minimal systemic toxicity. DRTS's Alpha DaRT platform is advancing in recurrent cutaneous squamous cell carcinoma…

the-decoder.com - Matthias Bastian - Apollo economist warns AI profit gains outside tech could take 'well beyond' what Wall Street expects
Apollo economist warns AI profit gains outside tech could take 'well beyond' what Wall Street expects
The Decoder

Outside tech, there's no sign AI is boosting profit margins, writes Torsten Slok, chief economist at US financial firm Apollo. AI company valuations rest entirely on the promise of rising margins at S&P 493 companies (the index minus 'the…

theguardian.com - Andrew Gregory - Burnham urged to ditch 'dangerous' UK-US NHS drug deal
Burnham urged to ditch 'dangerous' UK-US NHS drug deal
The Guardian

Andy Burnham is being urged to scrap the UK-US trade deal on medicines as health organisations and doctors' groups warn it is dangerous and prioritises pharmaceutical company profits over the lives of NHS patients. Ministers have defended the…

thehill.com - Caroline Vakil - Here's who could replace Platner if he drops out of Maine Senate race
Here's who could replace Platner if he drops out of Maine Senate race
The Hill

All eyes have turned to a handful of Maine Democrats who could take the mantle as Graham Platner, the party's current Senate nominee, faces growing pressure to withdraw from the marquee race over a sexual assault allegation. Politico reported…

Receive a Daily briefing on Pharma Industry News

Get Started